ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma.

Yang, Hai-Deng; Jin, Xiu-Xiu; Gu, Bin-Bin; Li, Dan; Yan, Ling-Ling

Yang, Hai-Deng; Jin, Xiu-Xiu; Gu, Bin-Bin; Li, Dan; Yan, Ling-Ling.

Afiliação

Yang HD; Key Laboratory of Minimally Invasive Techniques and Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China.
Jin XX; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Gu BB; Key Laboratory of Minimally Invasive Techniques and Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China.
Yu-Zhang; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Li D; Key Laboratory of Minimally Invasive Techniques and Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China.
Yan LL; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.

BMC Gastroenterol ; 23(1): 48, 2023 Feb 23.

Article em En | MEDLINE | ID: mdl-36823542

Assuntos

Fatores de Ribosilação do ADP; Adenocarcinoma; Neoplasias do Colo; Humanos; Adenocarcinoma/genética; Fatores de Ribosilação do ADP/genética; Biomarcadores; Adesão Celular; Citratos; Neoplasias do Colo/genética; Prognóstico

Palavras-chave

ARL9; Biomarker; Colon adenocarcinoma; Prognosis; The Cancer Genome Atla

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias do Colo / Fatores de Ribosilação do ADP Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google